Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 17, 2026 09:00 ET | Source: Kaléo

Kaléo Marks 25 Years Advancing Drug Delivery Technology

Glen Allen, VA, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-device combinations and auto-injector innovation, recognizes its 25th anniversary by celebrating the people, purpose,...
January 19, 2026 08:00 ET | Source: Kaléo

Kaléo Strengthens Leadership Team to Advance Drug Delivery and Autoinjector Innovation

Richmond, VA, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-delivery device technology and auto-injectors, today announced the appointment of Ram Halthore as Vice President,...
August 12, 2025 12:06 ET | Source: Kaléo

CORRECTION: Kaléo Receives Inaugural Medical CBRN Defense Consortium Innovation Award for Prototype Development of its Rapid Opioid Countermeasure System (Naloxone HCl Injection, USP) Antidote

Richmond, Virginia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-delivery device technology and auto-injector innovation, today announced it received the Prototype Innovation...
August 07, 2025 09:00 ET | Source: Kaléo

Kaléo Receives Inaugural Medical CBRN Defense Consortium Innovation Award for Prototype Development of its Rapid Opioid Countermeasure System (Naloxone HCl Injection, USP) Antidote

Richmond, Virginia, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-delivery device technology and auto-injector innovation, today announced it received the Prototype Innovation...
July 24, 2025 09:00 ET | Source: Kaléo

Kaleo’s AUVI-Q® (epinephrine injection, USP) Selected by Axiom Space to Help Protect Crew from Allergic Emergencies

Richmond, Virginia, July 24, 2025 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-delivery device technology and auto-injector innovation, today announced that AUVI-Q® (epinephrine injection,...
May 15, 2025 08:01 ET | Source: Kaléo

Retrospective Analysis of U.S. Claims Data Shows AUVI-Q® (epinephrine injection, USP) Prescription Associated with Lower Rates of Anaphylaxis-Related Inpatient Hospitalizations Compared to Other Epinephrine Auto-Injectors

Richmond, Virginia, May 15, 2025 (GLOBE NEWSWIRE) -- New findings from a retrospective analysis of U.S. commercial claims data indicate that patients prescribed AUVI-Q® (epinephrine injection, USP)...
April 23, 2025 08:04 ET | Source: Kaléo

NATIONAL ORGANIZATIONS UNITE TO PREPARE EARLY CHILDCARE FACILITIES FOR RISING INCIDENCE OF FOOD ALLERGIES

Richmond, Virginia, April 23, 2025 (GLOBE NEWSWIRE) -- A multi-disciplinary group of childcare professionals, healthcare providers, parents, and advocates, spearheaded by Kaléo, have united to form...